Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 137

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 5
Chunk 137
---
 associated with the Shire acquisition completed in the fiscal year ended March 31, 2019.

Table of Contents

Adjustments to Net Profit for the Year attributable to owners of the Company to calculate Core Net Profit for the Year attributable to owners of the Company:

                                                                                   For the Year Ended March 31, 2025                                                                                                                                                                                     
                                                                                   Reported                                       Amortization of intangible assets      Impairment of intangible assets      Other operating income/expenses      Others (1)      Core Financial Measures               
                                                                                   (IFRS)                                                                                                                                                                          (non-IFRS)                            
                                                                                   (billions of yen, except for percentages)                                                                                                                                                                             
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Operating profit                                                                 ¥                                              ¥                                      ¥                                    ¥                                    ¥               ¥                            1,162.6  
  Operating margin                                                                 7.5                                            —                                      —                                    —                                    —               25.4                                  
  Finance income (expenses), net                                                   (163.5)                                        —                                      —                                    —                                    22.8            (140.7)                               
  Share of profit (loss) of investments accounted for using the equity method      (4.0)                                          —                                      —                                    —                                    5.1             1.1                                   
  Profit before tax                                                                175.1                                          548.2                                  95.0                                 184.3                                20.4                                         1,023.1  
  Income tax (expenses) benefit (2)                                                (66.9)                                         (114.9)                                (23.4)                               (45.1)                               3.2             (247.3)                               
  Net profit for the year                                                          108.1                                          433.3                                  71.6                                 139.2                                23.6            775.8                                 
  Non-controlling interests                                                        0.2                                            —                                      —                                    —                                    —               0.2                                   
  Net profit for the year attributable to owners of the Company                    ¥                                              ¥                                      ¥                                    ¥                                    ¥               ¥                              775.6  

___________

Notes:

(1) Others: finance income (expenses), net, includes the loss on non-monetary items for subsidiaries in hyperinflationary economies and for which IAS29, Financial Reporting in Hyperinflationary